Risks of Proton Pump Inhibitors in Patients with Cirrhosis: Please Peruse the Indications
Digestive Diseases and Sciences(2024)
Abstract
The use of proton pump inhibitor (PPI) in cirrhotic patients can be associated with increased risks of long-term mortality, decompensation, hepatic encephalopathy, spontaneous bacterial peritonitis, and infection, but not with short-term mortality. Ensure clear indications at lowest effective dose of is mandatory for the use of PPI among cirrhotic patients.
MoreTranslated text
Key words
Cirrhosis,Proton pump inhibitors,Hepatocellular carcinoma,Hepatic decompensation,Spontaneous bacterial peritonitis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined